Skip to main contentAll experts

DrByron Arana Figueroa

Head, Cutaneous Leishmaniasis

Drugs for Neglected Diseases Initiative

  • Head, Cutaneous Leishmaniasis
    Drugs for Neglected Diseases Initiative
  • 41 22 906 9258 (Work)
  • Drugs for Neglected Diseases Initiative, 15 Chemin Louis-Dunant, Geneva, 1202, Switzerland

GRANTS

  • GRANT
    Improved VL case detection & vector control for the support of VL elimination initiative in Bangladesh & Nepal
    TDR1 Jan 2014
  • GRANT
    Data mangement, clinical dengue study
    TDR1 Jan 2005
  • GRANT
    Chagas disease seroprevalence among school age children in endemic area of Guatemala
    TDR1 Jan 1998
  • GRANT
    Ph.D. for Dr B. Arana Figueroa: field expenses for studies on improved control of cutaneous leishmaniasis in Guatemala
    TDR1 Jan 1996
  • GRANT
    Ph.D. for Dr B. Arana: improved control of cutaneous leish. in GUT: identify risk factors and topical treatment
    TDR1 Jan 1994
  • GRANT
    Assessment of health education interventions directed at cutaneous leishmaniasis in Guatemala
    TDR1 Jan 1992
  • GRANT
    IFN-gamma plus glucantime in the treatment of cutaneous leishmaniasis in Guatemala
    TDR1 Jan 1992
  • GRANT
    Risks factors associated to cutaneous leishmaniasis in Guatemala
    TDR1 Jan 1992
  • GRANT
    IFN-gamma plus glucantime in the treatment of cutaneous leishmaniasis in Guatemala
    TDR1 Jan 1990
  • GRANT
    Eval. of itraconazole, ketoconazole and meglumine antimon- ate (glucantime) in treatment of American cutaneous leish.
    TDR1 Jan 1988